• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RscreenOrm:用于更具可重复性的命中选择的 CRISPR 和 siRNA 筛选数据的归一化。

Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.

机构信息

Department of Otolaryngology - Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081, HV, The Netherlands.

Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, 1007, MB, The Netherlands.

出版信息

BMC Bioinformatics. 2018 Aug 20;19(1):301. doi: 10.1186/s12859-018-2306-z.

DOI:10.1186/s12859-018-2306-z
PMID:30126372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6102854/
Abstract

BACKGROUND

Reproducibility of hits from independent CRISPR or siRNA screens is poor. This is partly due to data normalization primarily addressing technical variability within independent screens, and not the technical differences between them.

RESULTS

We present "rscreenorm", a method that standardizes the functional data ranges between screens using assay controls, and subsequently performs a piecewise-linear normalization to make data distributions across all screens comparable. In simulation studies, rscreenorm reduces false positives. Using two multiple-cell lines siRNA screens, rscreenorm increased reproducibility between 27 and 62% for hits, and up to 5-fold for non-hits. Using publicly available CRISPR-Cas screen data, application of commonly used median centering yields merely 34% of overlapping hits, in contrast with rscreenorm yielding 84% of overlapping hits. Furthermore, rscreenorm yielded at most 8% discordant results, whilst median-centering yielded as much as 55%.

CONCLUSIONS

Rscreenorm yields more consistent results and keeps false positive rates under control, improving reproducibility of genetic screens data analysis from multiple cell lines.

摘要

背景

独立的 CRISPR 或 siRNA 筛选的命中率重现性较差。这在一定程度上是由于数据归一化主要针对独立筛选中的技术变异性,而不是它们之间的技术差异。

结果

我们提出了“rscreenorm”,这是一种使用测定对照物在屏幕之间标准化功能数据范围的方法,然后进行分段线性归一化以使所有屏幕上的数据分布具有可比性。在模拟研究中,rscreenorm 减少了假阳性。使用两个多细胞系 siRNA 筛选,rscreenorm 增加了命中的重现性,从 27%到 62%不等,而非命中的重现性高达 5 倍。使用公开的 CRISPR-Cas 筛选数据,常用的中位数中心化仅产生 34%的重叠命中,而 rscreenorm 则产生 84%的重叠命中。此外,rscreenorm 最多产生 8%的不一致结果,而中位数中心化则产生高达 55%的不一致结果。

结论

rscreenorm 产生更一致的结果,并控制假阳性率,从而提高了来自多个细胞系的遗传筛选数据分析的重现性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/13504f4a1e11/12859_2018_2306_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/34d6669fa97e/12859_2018_2306_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/e3291c2612a5/12859_2018_2306_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/5515e6309be4/12859_2018_2306_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/8b19bea4a146/12859_2018_2306_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/13504f4a1e11/12859_2018_2306_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/34d6669fa97e/12859_2018_2306_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/e3291c2612a5/12859_2018_2306_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/5515e6309be4/12859_2018_2306_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/8b19bea4a146/12859_2018_2306_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef1/6102854/13504f4a1e11/12859_2018_2306_Fig5_HTML.jpg

相似文献

1
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.RscreenOrm:用于更具可重复性的命中选择的 CRISPR 和 siRNA 筛选数据的归一化。
BMC Bioinformatics. 2018 Aug 20;19(1):301. doi: 10.1186/s12859-018-2306-z.
2
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.CRISPR 筛选提供了对癌症易损性的全面评估,但对高度扩增的基因组区域产生了假阳性结果。
Cancer Discov. 2016 Aug;6(8):900-13. doi: 10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.
3
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes.对用于必需基因的CRISPR/Cas9和RNA干扰筛选进行系统比较。
Nat Biotechnol. 2016 Jun;34(6):634-6. doi: 10.1038/nbt.3567. Epub 2016 May 9.
4
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.CRISPR 敲除筛选在鉴定必需基因方面优于 shRNA 和 CRISPRi。
Nat Biotechnol. 2016 Jun;34(6):631-3. doi: 10.1038/nbt.3536. Epub 2016 Apr 25.
5
Genomic Amplifications Cause False Positives in CRISPR Screens.基因组扩增在CRISPR筛选中导致假阳性。
Cancer Discov. 2016 Aug;6(8):824-6. doi: 10.1158/2159-8290.CD-16-0665.
6
RNAi/CRISPR Screens: from a Pool to a Valid Hit.RNAi/CRISPR 筛选:从库到有效命中。
Trends Biotechnol. 2019 Jan;37(1):38-55. doi: 10.1016/j.tibtech.2018.08.002. Epub 2018 Aug 31.
7
Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells.全基因组 CRISPR 筛选揭示 PSMA6 是胰腺癌细胞中的必需基因。
BMC Cancer. 2019 Mar 21;19(1):253. doi: 10.1186/s12885-019-5455-1.
8
Genetic screens and functional genomics using CRISPR/Cas9 technology.利用 CRISPR/Cas9 技术进行遗传筛选和功能基因组学研究。
FEBS J. 2015 Apr;282(8):1383-93. doi: 10.1111/febs.13248. Epub 2015 Mar 16.
9
A permutation-based non-parametric analysis of CRISPR screen data.基于排列的CRISPR筛选数据非参数分析。
BMC Genomics. 2017 Jul 19;18(1):545. doi: 10.1186/s12864-017-3938-5.
10
Reproducibility metrics for context-specific CRISPR screens.针对特定情境的 CRISPR 筛选的可重复性指标。
Cell Syst. 2023 May 17;14(5):418-422.e2. doi: 10.1016/j.cels.2023.04.003.

引用本文的文献

1
ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data.ShrinkCRISPR:一种用于 CRISPR-Cas9 筛选数据差异适合度分析的灵活方法。
BMC Bioinformatics. 2023 Feb 3;24(1):36. doi: 10.1186/s12859-023-05142-1.
2
Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma.全基因组 siRNA 筛选鉴定 RBBP9 功能作为 Fanconi 贫血缺陷型头颈部鳞状细胞癌的一个潜在靶点。
Commun Biol. 2023 Jan 13;6(1):37. doi: 10.1038/s42003-022-04389-3.
3
Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

本文引用的文献

1
Cas-analyzer: an online tool for assessing genome editing results using NGS data.Cas分析器:一种使用NGS数据评估基因组编辑结果的在线工具。
Bioinformatics. 2017 Jan 15;33(2):286-288. doi: 10.1093/bioinformatics/btw561. Epub 2016 Aug 24.
2
Analyzing CRISPR genome-editing experiments with CRISPResso.使用CRISPResso分析CRISPR基因编辑实验。
Nat Biotechnol. 2016 Jul 12;34(7):695-7. doi: 10.1038/nbt.3583.
3
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.高分辨率 CRISPR 筛选揭示了适应性基因和基因型特异性的癌症易感性。
功能性筛选抑制人宫颈癌细胞锚定非依赖性生长的 microRNAs。
Int J Mol Sci. 2022 Apr 26;23(9):4791. doi: 10.3390/ijms23094791.
4
Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications.头颈部(癌前)癌症的靶向治疗:临床前靶点识别与新型治疗应用的开发
Cancers (Basel). 2021 Jun 3;13(11):2774. doi: 10.3390/cancers13112774.
5
Deletion of morpholino binding sites (DeMOBS) to assess specificity of morphant phenotypes.利用 morpholino 结合位点缺失(DeMOBS)评估嵌合体表型的特异性。
Sci Rep. 2020 Sep 21;10(1):15366. doi: 10.1038/s41598-020-71708-1.
6
Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.沉默核心剪接体 Sm 基因表达可诱导非小细胞肺癌细胞中蛋白酶体亚基β3 mRNA 的细胞毒性剪接转换。
Int J Mol Sci. 2020 Jun 12;21(12):4192. doi: 10.3390/ijms21124192.
7
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death.通过抑制Chk1靶向头颈部癌的细胞周期:双峰细胞死亡的新概念
Oncogenesis. 2019 Jun 17;8(7):38. doi: 10.1038/s41389-019-0147-x.
8
High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome.高通量 RNAi 筛选揭示了 RNA 剪接体中的癌症选择性致死靶标。
Oncogene. 2019 May;38(21):4142-4153. doi: 10.1038/s41388-019-0711-z. Epub 2019 Jan 31.
Cell. 2015 Dec 3;163(6):1515-26. doi: 10.1016/j.cell.2015.11.015. Epub 2015 Nov 25.
4
AGEseq: Analysis of Genome Editing by Sequencing.AGEseq:通过测序进行基因组编辑分析。
Mol Plant. 2015 Sep;8(9):1428-30. doi: 10.1016/j.molp.2015.06.001. Epub 2015 Jun 6.
5
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.为工作选择合适的工具:RNA干扰、转录激活样效应因子核酸酶还是规律成簇间隔短回文重复序列。
Mol Cell. 2015 May 21;58(4):575-85. doi: 10.1016/j.molcel.2015.04.028.
6
High-throughput functional genomics using CRISPR-Cas9.使用CRISPR-Cas9的高通量功能基因组学。
Nat Rev Genet. 2015 May;16(5):299-311. doi: 10.1038/nrg3899. Epub 2015 Apr 9.
7
Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC.全基因组siRNA筛选确定下调MASTL和FOXM1对非小细胞肺癌的放射增敏作用。
Mol Cancer Ther. 2015 Jun;14(6):1434-44. doi: 10.1158/1535-7163.MCT-14-0846. Epub 2015 Mar 25.
8
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.MAGeCK能够从全基因组规模的CRISPR/Cas9基因敲除筛选中可靠地鉴定必需基因。
Genome Biol. 2014;15(12):554. doi: 10.1186/s13059-014-0554-4.
9
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.全基因组 RNAi 筛选揭示了 REV3 在应对复制压力中的关键作用。
Mol Oncol. 2014 Dec;8(8):1747-59. doi: 10.1016/j.molonc.2014.07.008. Epub 2014 Jul 22.
10
The Good, the Bad, and the Ugly: in search of gold standards for assessing functional genetic screen quality.好、坏与丑:探寻评估功能基因筛选质量的金标准
Mol Syst Biol. 2014 Jul 1;10(7):738. doi: 10.15252/msb.20145372.